1-4 of 4
Catherine Billups
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts

Santi Suryani, Hernan Carol, Triona Ni Chonghaile, Viktoras Frismantas, Chintanu Sarmah, Laura High, Beat Bornhauser, Mark J. Cowley, Barbara Szymanska, Kathryn Evans, Ingrid Boehm, Elise Tonna, Luke Jones, Donya Moradi Manesh, Raushan T. Kurmasheva, Catherine Billups, Warren Kaplan, Anthony Letai, Jean-Pierre Bourquin, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (17): 4520–4531.
https://doi.org/10.1158/1078-0432.CCR-14-0259
Published: 01 September 2014
View article titled, Cell and Molecular Determinants of <em>In Vivo</em> Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts
Open the PDF for Cell and Molecular Determinants of <em>In Vivo</em> Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts in another window
Includes: Supplementary data
Journal Articles

Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent

Emilia M. Pinto, Christopher Morton, Carlos Rodriguez-Galindo, Lisa McGregor, Andrew M. Davidoff, Kimberly Mercer, Larisa V. Debelenko, Catherine Billups, Raul C. Ribeiro, Gerard P. Zambetti
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (7): 1740–1747.
https://doi.org/10.1158/1078-0432.CCR-12-3354
Published: 02 April 2013
View article titled, Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent
Open the PDF for Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent in another window
Includes: Supplementary data
Journal Articles

Relation between Irofulven (MGI-114) Systemic Exposure and Tumor Response in Human Solid Tumor Xenografts

Markos Leggas, Clinton F. Stewart, Michael H. Woo, Maryam Fouladi, Pamela J. Cheshire, Jennifer K. Peterson, Henry S. Friedman, Catherine Billups, Peter J. Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (9): 3000–3007.
Published: 01 September 2002
View article titled, Relation between Irofulven (MGI-114) Systemic Exposure and Tumor Response in Human Solid Tumor Xenografts
Open the PDF for Relation between Irofulven (MGI-114) Systemic Exposure and Tumor Response in Human Solid Tumor Xenografts in another window
Journal Articles

Modulation of the Fas Signaling Pathway by IFN-γ in Therapy of Colon Cancer: Phase I Trial and Correlative Studies of IFN-γ, 5-Fluorouracil, and Leucovorin

Lee S. Schwartzberg, Istvan Petak, Clinton Stewart, P. Kellie Turner, Jeri Ashley, David M. Tillman, Leslie Douglas, Ming Tan, Catherine Billups, Rudolf Mihalik, Alva Weir, Kurt Tauer, Steve Shope, Janet A. Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (8): 2488–2498.
Published: 01 August 2002
View article titled, Modulation of the Fas Signaling Pathway by IFN-γ in Therapy of Colon Cancer: Phase I Trial and Correlative Studies of IFN-γ, 5-Fluorouracil, and Leucovorin
Open the PDF for Modulation of the Fas Signaling Pathway by IFN-γ in Therapy of Colon Cancer: Phase I Trial and Correlative Studies of IFN-γ, 5-Fluorouracil, and Leucovorin in another window